OwnershipPublicly listed · Nasdaq: NMTCSEC EDGAR company record and tickers file (Nasdaq: NMTC) · checked Oct 28, 2026
Commercial developmentNot yet assessedWe only state a stage once a source supports it. Having a product on sale does not show it works or makes money.
Investment accessVerified public listingListed as Nasdaq: NMTC, per the SEC's company tickers file. A listing means shares trade publicly; it says nothing about whether they are a good investment.Source · checked Oct 28, 2026
Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Next scheduled recheck: Nov 27, 2026.
5developments published
—US federal obligations on record
9private-offering notices since 2019
Oct 5, 2026latest development
Timeline
- Oct 5, 2026 · Reported results
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
Company-reported - Aug 27, 2026 · Company announcement
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED™ Platform
Company-reported - Aug 13, 2026 · Reported results
NeuroOne® Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%
Company-reported - May 21, 2026 · Restatement
NeuroOne® Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
Company-reported - May 12, 2026 · Reported results
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Company-reported
Profile
- Legal name
- NEUROONE MEDICAL TECHNOLOGIES Corp
- Listing
- Nasdaq NMTC
- SEC filer
- CIK 0001500198 ↗
- SEC industry code
- Surgical & Medical Instruments & Apparatus
- Incorporated
- DE
- Coverage
- Filings + federal awards
Mix of developments
Watch NeuroOne Medical
Anything new from NeuroOne Medical lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digestPrivate offerings reported to the SEC (Form D)
A Form D is a notice a company files after selling securities without a public registration. Amount sold is cumulative for that offering as reported by the company; an amendment (D/A) updates an earlier notice, so rows are not added together. None of these is a valuation or an open offer.
| Filed | Form | Amount sold | Offering size | First sale | Investors | Exemption | Record |
|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | D | $276,043 | $276,043 | Aug 2, 2024 | 20 | Rule 506(b) | SEC ↗ |
| Jan 27, 2021 | D | $12.5 million | $12.5 million | Jan 14, 2021 | 36 | Rule 506(b) | SEC ↗ |
| Aug 10, 2020 | D | $135,000 | $135,000 | Jul 28, 2020 | 1 | Rule 506(b) | SEC ↗ |
| May 14, 2020 | D | $2.5 million | $6.0 million | Apr 30, 2020 | 33 | Rule 506(b) | SEC ↗ |
| Nov 7, 2019 | D | $255,000 | $1.0 million | Oct 23, 2019 | 3 | Rule 506(b) | SEC ↗ |
| Nov 7, 2019 | D | $1.3 million | $3.0 million | Nov 1, 2019 | 16 | Rule 506(b) | SEC ↗ |
| Feb 27, 2019 | D/A | $992,500 | $10.0 million | Dec 28, 2018 | 17 | Rule 506(b) | SEC ↗ |
| Feb 27, 2019 | D/A | $1.5 million | $10.0 million | Jul 9, 2018 | 21 | Rule 506(b) | SEC ↗ |
| Jan 4, 2019 | D | $400,000 | $10.0 million | Dec 28, 2018 | 3 | Rule 506(b) | SEC ↗ |